{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T03:53:29Z","timestamp":1783569209057,"version":"3.55.0"},"reference-count":29,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.3892\/mmr.2017.7165","type":"journal-article","created":{"date-parts":[[2017,8,4]],"date-time":"2017-08-04T07:09:36Z","timestamp":1501830576000},"page":"5050-5054","source":"Crossref","is-referenced-by-count":13,"title":["Oxidored-nitro domain-containing protein 1 promotes liver fibrosis by activating the Wnt\/\u03b2-catenin signaling pathway in vitro"],"prefix":"10.3892","volume":"16","author":[{"given":"Tianxin","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanfei","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangxiong","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhua","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2017,8,4]]},"reference":[{"key":"key20180108002820_b1-mmr-16-04-5050","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S0168-8278(02)00429-4","article-title":"Liver fibrosis-from bench to bedside","volume":"38","author":"Friedman","year":"2003","journal-title":"J Hepatol"},{"key":"key20180108002820_b2-mmr-16-04-5050","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/j.clinre.2015.06.011","article-title":"New therapies for hepatic fibrosis","volume":"39","author":"Koyama","year":"2015","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"key20180108002820_b3-mmr-16-04-5050","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis","volume":"132","author":"El-Serag","year":"2007","journal-title":"Gastroenterology"},{"key":"key20180108002820_b4-mmr-16-04-5050","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000050692","article-title":"Hepatocellular carcinoma: An Asian perspective","volume":"19","author":"Teo","year":"2001","journal-title":"Dig Dis"},{"key":"key20180108002820_b5-mmr-16-04-5050","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","article-title":"Hepatocellular carcinoma","volume":"379","author":"Forner","year":"2012","journal-title":"Lancet"},{"key":"key20180108002820_b6-mmr-16-04-5050","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"American Association for the Study of Liver Diseases: Management of hepatocellular carcinoma: An update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"key20180108002820_b7-mmr-16-04-5050","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00432-003-0451-9","article-title":"Cloning, expression, and mutation analysis of NOR1, a novel human gene down-regulated in HNE1 nasopharyngeal carcinoma cell line","volume":"129","author":"Nie","year":"2003","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20180108002820_b8-mmr-16-04-5050","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.3892\/or.2016.4550","article-title":"MicroRNA-199a-5p inhibits VEGF-induced tumorigenesis through targeting oxidored-nitro domain-containing protein 1 in human HepG2 cells","volume":"35","author":"Gui","year":"2016","journal-title":"Oncol Rep"},{"key":"key20180108002820_b9-mmr-16-04-5050","first-page":"164","article-title":"Effects of a novel gene NOR(1) on the protein expression of HepG2 cell line","volume":"24","author":"Nie","year":"2008","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"key":"key20180108002820_b10-mmr-16-04-5050","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3892\/ol.2012.774","article-title":"Inhibition of Grb2-mediated activation of MAPK signal transduction suppresses NOR1\/CB1954-induced cytotoxicity in the HepG2 cell line","volume":"4","author":"Gui","year":"2012","journal-title":"Oncol Lett"},{"key":"key20180108002820_b11-mmr-16-04-5050","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.3892\/ol.2016.4362","article-title":"Oxidored-nitro domain-containing protein 1 expression is associated with the progression of hepatocellular carcinoma","volume":"11","author":"Li","year":"2016","journal-title":"Oncol Lett"},{"key":"key20180108002820_b12-mmr-16-04-5050","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20180108002820_b13-mmr-16-04-5050","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3892\/or.2012.2101","article-title":"Overexpression of oxidored-nitro domain containing protein 1 inhibits human nasopharyngeal carcinoma and cervical cancer cell proliferation and induces apoptosis: Involvement of mitochondrial apoptotic pathways","volume":"29","author":"Ouyang","year":"2013","journal-title":"Oncol Rep"},{"key":"key20180108002820_b14-mmr-16-04-5050","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.3892\/or.2014.3407","article-title":"Overexpression of oxidored-nitro domain containing protein 1 induces growth inhibition and apoptosis in human prostate cancer PC3 cells","volume":"32","author":"Shan","year":"2014","journal-title":"Oncol Rep"},{"key":"key20180108002820_b15-mmr-16-04-5050","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/hep.25613","article-title":"Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis","volume":"56","author":"Lakner","year":"2012","journal-title":"Hepatology"},{"key":"key20180108002820_b16-mmr-16-04-5050","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1053\/j.gastro.2004.10.003","article-title":"Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis","volume":"128","author":"Oakley","year":"2005","journal-title":"Gastroenterology"},{"key":"key20180108002820_b17-mmr-16-04-5050","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1582-4934.2006.tb00292.x","article-title":"Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets","volume":"10","author":"Gressner","year":"2006","journal-title":"J Cell Mol Med"},{"key":"key20180108002820_b18-mmr-16-04-5050","first-page":"27","article-title":"Hepatic fibrosis-role of hepatic stellate cell activation","volume":"4","author":"Safadi","year":"2002","journal-title":"MedGenMed"},{"key":"key20180108002820_b19-mmr-16-04-5050","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/j.cellsig.2012.07.023","article-title":"The potential of microRNAs in liver fibrosis","volume":"24","author":"He","year":"2012","journal-title":"Cell Signal"},{"key":"key20180108002820_b20-mmr-16-04-5050","doi-asserted-by":"crossref","first-page":"e0161988","DOI":"10.1371\/journal.pone.0161988","article-title":"Stimulation of transforming growth factor-\u03b21-induced Endothelial-To-Mesenchymal transition and tissue fibrosis by Endothelin-1 (ET-1): A novel profibrotic effect of ET-1","volume":"11","author":"Wermuth","year":"2016","journal-title":"PLoS One"},{"key":"key20180108002820_b21-mmr-16-04-5050","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-\u03b2: The master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"key20180108002820_b22-mmr-16-04-5050","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pharmthera.2015.10.003","article-title":"TGF-\u03b2\/BMP proteins as therapeutic targets in renal fibrosis. Where have we arrived after 25 years of trials and tribulations?","volume":"156","author":"Mu\u00f1oz-F\u00e9lix","year":"2015","journal-title":"Pharmacol Ther"},{"key":"key20180108002820_b23-mmr-16-04-5050","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1096\/fj.03-1273rev","article-title":"TGF-beta signaling and the fibrotic response","volume":"18","author":"Leask","year":"2004","journal-title":"FASEB J"},{"key":"key20180108002820_b24-mmr-16-04-5050","first-page":"609","article-title":"Screening of genes differentially expressed in HepG2 cells transfected with NOR1 gene using DNA microarray","volume":"14","author":"Shen","year":"2007","journal-title":"Practical Prev Med"},{"key":"key20180108002820_b25-mmr-16-04-5050","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1016\/j.biochi.2013.09.003","article-title":"Wnt signaling in liver fibrosis: Progress, challenges and potential directions","volume":"95","author":"Miao","year":"2013","journal-title":"Biochimie"},{"key":"key20180108002820_b26-mmr-16-04-5050","doi-asserted-by":"crossref","first-page":"337","DOI":"10.33549\/physiolres.932289","article-title":"Wnt\/beta-catenin signaling: A promising new target for fibrosis diseases","volume":"61","author":"Guo","year":"2012","journal-title":"Physiol Res"},{"key":"key20180108002820_b27-mmr-16-04-5050","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.dld.2011.02.016","article-title":"Pokeweed antiviral protein down-regulates Wnt\/\u03b2-catenin signalling to attenuate liver fibrogenesis in vitro and in vivo","volume":"43","author":"Li","year":"2011","journal-title":"Dig Liver Dis"},{"key":"key20180108002820_b28-mmr-16-04-5050","doi-asserted-by":"crossref","first-page":"G39","DOI":"10.1152\/ajpgi.00263.2007","article-title":"Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis","volume":"294","author":"Cheng","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"key20180108002820_b29-mmr-16-04-5050","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.3892\/mmr.2014.2099","article-title":"\u03b2-catenin is overexpressed in hepatic fibrosis and blockage of Wnt\/\u03b2-catenin signaling inhibits hepatic stellate cell activation","volume":"9","author":"Ge","year":"2014","journal-title":"Mol Med Rep"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T05:35:26Z","timestamp":1602653726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2017.7165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,4]]},"references-count":29,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,8,4]]},"published-print":{"date-parts":[[2017,10]]}},"alternative-id":["10.3892\/mmr.2017.7165"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2017.7165","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,4]]}}}